<?xml version="1.0" encoding="UTF-8"?>
<p id="Par54">Metformin has commonly been used as the first line pharmacologic agent for treating diabetes and pre-diabetes as per the American Diabetes Association guidelines [
 <xref ref-type="bibr" rid="CR18">18</xref>]. Metformin improves glycemic control by decreasing hepatic glucose production, decreasing glucose absorption in the intestines and stomach, and increasing insulin-mediated glucose uptake [
 <xref ref-type="bibr" rid="CR19">19</xref>]. Metformin has shown cardio-protective effects by increasing endothelial progenitor cells and CFU-Hill's colonies in type 1 diabetes, and is known to also have cardio-protective properties in type 2 diabetes [
 <xref ref-type="bibr" rid="CR20">20</xref>â€“
 <xref ref-type="bibr" rid="CR22">22</xref>].
</p>
